clinical trials

You have access
The Australasian Radiopharmaceutical Trials Network (ARTnet) – Clinical Trials, Evidence and Opportunity.
Roslyn Francis, Dale Bailey, Michael S Hofman and Andrew Scott

Journal of Nuclear Medicine December 31, 2020, jnumed.120.258152; DOI: https://doi.org/10.2967/jnumed.120.258152
You have access
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2
Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1020-1027; DOI: https://doi.org/10.2967/jnumed.117.204651
You have access
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis

Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338
You have access
Molecular Imaging Biomarkers for Oncology Clinical Trials
David A. Mankoff, Daniel A. Pryma and Amy S. Clark

Journal of Nuclear Medicine April 1, 2014, 55 (4) 525-528; DOI: https://doi.org/10.2967/jnumed.113.126128
You have access
Interim ¹⁸F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?
Lale Kostakoglu and Andrea Gallamini

Journal of Nuclear Medicine July 1, 2013, 54 (7) 1082-1093; DOI: https://doi.org/10.2967/jnumed.113.120451

Main menu